British American Tobacco p.l.c. [BTI] is 6.44% higher this YTD. Is it still time to buy?



British American Tobacco p.l.c. [NYSE: BTI] slipped around -0.46 points on Thursday, while shares priced at $39.82 at the close of the session, down -1.14%. The company report on April 11, 2022 that Bioasis Enters Into Research Collaboration With Janssen.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


BIOASIS TECHNOLOGIES INC. (TSXV:BTI.V; OTCQB:BIOAF), (the “Company or “Bioasis”), a biopharmaceutical company developing its proprietary xB3TM platform technology for the delivery of therapeutics across the blood-brain barrier (the “BBB”), announced today that it has entered into a research collaboration with Janssen Biotech, Inc., one of the Pharmaceutical Companies of Johnson & Johnson. Under the terms of the agreement, Janssen will have the option to research, develop and commercialize novel products based on Bioasis’ xB3TM platform. The agreement was facilitated by Johnson & Johnson Innovation.

“The unique delivery method of the xB3TM platform has the potential to overcome a significant challenge in the treatment of brain disorders, which is the ability to cross the blood-brain barrier. We are very pleased to have entered into this agreement and excited to be working with Janssen. Our xB3TM BBB drug delivery platform has the potential to significantly advance the treatment of disease, solving a major unmet clinical need and improving the lives of patients,” said Deborah Rathjen, Ph.D., Bioasis’ Executive Chair.

British American Tobacco p.l.c. stock is now 6.44% up from its year-to-date (YTD) trading value. BTI Stock saw the intraday high of $39.95 and lowest of $39.44 per share. The company’s 52-week high price is 47.24, which means current price is +6.47% above from all time high which was touched on 02/17/22.

Compared to the average trading volume of 2.91M shares, BTI reached a trading volume of 3410555 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about British American Tobacco p.l.c. [BTI]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BTI shares is $52.83 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BTI stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

JP Morgan have made an estimate for British American Tobacco p.l.c. shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on March 24, 2022. The new note on the price target was released on April 09, 2021, representing the official price target for British American Tobacco p.l.c. stock.

The Average True Range (ATR) for British American Tobacco p.l.c. is set at 0.91, with the Price to Sales ratio for BTI stock in the period of the last 12 months amounting to 2.90. The Price to Book ratio for the last quarter was 1.13, with the Price to Cash per share for the same quarter was set at 1.75. Price to Free Cash Flow for BTI in the course of the last twelve months was 17.37 with Quick ratio for the last quarter at 0.50.

How has BTI stock performed recently?

British American Tobacco p.l.c. [BTI] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -1.80. With this latest performance, BTI shares dropped by -4.96% in over the last four-week period, additionally sinking by -1.44% over the last 6 months – not to mention a rise of 2.08% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BTI stock in for the last two-week period is set at 34.45, with the RSI for the last a single of trading hit 28.97, and the three-weeks RSI is set at 38.26 for British American Tobacco p.l.c. [BTI]. The present Moving Average for the last 50 days of trading for this stock 42.68, while it was recorded at 40.25 for the last single week of trading, and 40.26 for the last 200 days.

British American Tobacco p.l.c. [BTI]: Deeper insight into the fundamentals

British American Tobacco p.l.c.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.50 and a Current Ratio set at 0.80.

Earnings analysis for British American Tobacco p.l.c. [BTI]

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for BTI. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for British American Tobacco p.l.c. go to 8.90%.

Insider trade positions for British American Tobacco p.l.c. [BTI]

There are presently around $5,928 million, or 6.80% of BTI stock, in the hands of institutional investors. The top three institutional holders of BTI stocks are: GQG PARTNERS LLC with ownership of 29,035,870, which is approximately 91.321% of the company’s market cap and around 4.60% of the total institutional ownership; ORBIS ALLAN GRAY LTD, holding 15,114,612 shares of the stock with an approximate value of $608.82 million in BTI stocks shares; and CAPITAL INTERNATIONAL INVESTORS, currently with $380.61 million in BTI stock with ownership of nearly 12.637% of the company’s market capitalization.

319 institutional holders increased their position in British American Tobacco p.l.c. [NYSE:BTI] by around 30,842,802 shares. Additionally, 182 investors decreased positions by around 6,992,078 shares, while 100 investors held positions by with 109,329,408 shares. The mentioned changes placed institutional holdings at 147,164,288 shares, according to the latest SEC report filing. BTI stock had 71 new institutional investments in for a total of 2,248,021 shares, while 54 institutional investors sold positions of 797,417 shares during the same period.